Abstract
Post-traumatic stress disorder (PTSD), which normally follows psychological trauma, has been increasingly studied as a brain disease. However, the blood-brain barrier (BBB) prevents conventional drugs for PTSD from entering the brain. Our previous studies proved the effectiveness of cannabidiol (CBD) against PTSD, but low water solubility, low brain targeting efficiency and poor bioavailability restricted its applications. Here, a bionic delivery system, camouflage CBD-loaded macrophage-membrane nanovesicles (CMNVs), was constructed via co-extrusion of CBD with macrophage membranes, which had inflammatory and immune escape properties. In vitro anti-inflammatory, cellular uptake and pharmacokinetic experiments respectively verified the anti-inflammatory, inflammatory targeting and immune escape properties of CMNVs. Brain targeting and excellent anti-PTSD effects of CMNVs had been validated in vivo by imaging and pharmacodynamics studies. In our study, the potential of ultrasound to open BBBs and improve the brain-targeted delivery of CBD was evaluated. In conclusion, this cell membrane bionic delivery system assisted with ultrasound had good therapeutic effect against PTSD mice, which is expected to help convey CBD to inflammatory areas within the brain and alleviate the symptoms of PTSD.
Keywords: Brain–targeted delivery, Cannabidiol, Macrophage membrane, Post–traumatic stress disorder (PTSD)
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Intranasal temperature-sensitive hydrogels of cannabidiol inclusion complex for the treatment of post-traumatic stress disorder.Acta Pharm Sin B. 2021 Jul;11(7):2031-2047. doi: 10.1016/j.apsb.2021.01.014. Epub 2021 Jan 24.PMID: 34386336 Free PMC article.
-
Comparison between cannabidiol and sertraline for the modulation of post-traumatic stress disorder-like behaviors and fear memory in mice.Psychopharmacology (Berl). 2022 May;239(5):1605-1620. doi: 10.1007/s00213-022-06132-6. Epub 2022 Apr 9.PMID: 35396940
-
Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series.J Altern Complement Med. 2019 Apr;25(4):392-397. doi: 10.1089/acm.2018.0437. Epub 2018 Dec 13.PMID: 30543451 Free PMC article.
-
Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder.IBRO Neurosci Rep. 2021 Aug 21;11:88-102. doi: 10.1016/j.ibneur.2021.08.001. eCollection 2021 Dec.PMID: 34485973 Free PMC article. Review.
-
Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials.Front Neurosci. 2018 Jul 24;12:502. doi: 10.3389/fnins.2018.00502. eCollection 2018.PMID: 30087591 Free PMC article. Review.